Key Financial Figures

Consolidated Performance:

  • Sales: ₹2,852 crore in Q1 FY27 compared to ₹2,603 crore in Q1 FY26, representing growth.
  • Profit Before Tax (PBT)*: ₹172 crore in Q1 FY27 compared to ₹188 crore in Q1 FY26.

*Excludes share of profit from Joint Venture and non-recurring items.

Managing Director's Comments

Mr. Sunil Kataria, CEO & Managing Director, described the Q1 FY27 performance as resilient with double-digit sales growth despite a challenging environment marked by delayed monsoon conditions and geopolitical tensions causing inflationary pressures. Profitability was impacted by temporary cost headwinds in select businesses. The company highlighted robust volume-led growth across most businesses, improved net working capital discipline, and a focus on building a customer-centric organization with sharp execution.

Segment-Wise Business Highlights

Animal Nutrition:

  • Delivered robust topline growth with strong demand-led volume expansion and improved realizations.
  • Cattle feed volumes grew approximately 15% Year-over-Year (YoY).
  • Underlying segment results improved by approximately 36% YoY due to strategic commodity sourcing, operating leverage, and cost discipline.

Oil Palm:

  • Segment revenue grew driven by improved realizations and higher sales volumes.
  • Fresh Fruit Bunch (FFB) volumes remained broadly flat against a high comparable base in Q1 FY26.
  • Segment result increased YoY supported by enhanced oil extraction efficiency and higher realizations.

Crop Care (Standalone):

  • Demand was muted due to delayed monsoon progress and slower kharif sowings following one of the driest Junes in over a decade.
  • Segment revenue de-grew predominantly due to lower volumes of in-house cotton herbicide.
  • Strategic diversification showed strong footing with successful scale-up of new products Ashitaka (Maize Herbicide) and Takai (Paddy insecticide), which helped partially mitigate the impact.
  • Significant volume reduction resulted in margin contraction.

Astec LifeSciences:

  • Sustained recovery momentum with substantial improvement in EBITDA over Q1 FY26, achieving EBITDA break-even.
  • Improvement was driven by margin expansion across both Enterprise and CDMO categories and higher capacity utilization.
  • Marginal revenue de-growth occurred primarily due to a change in product mix.

Dairy:

  • Delivered healthy revenue growth in Q1 FY27 compared to Q1 FY26, primarily driven by strong volume growth in value-added products.
  • Salience of value-added products improved from 42% in Q1 FY26 to 49% in Q1 FY27.
  • Q1 FY27 EBITDA was impacted by elevated milk procurement prices amid industry-wide constraints and war-led inflation in certain other inputs.

Godrej Foods Limited (GFL):

  • Branded volume salience grew approximately 6% YoY, supporting stable revenues.
  • EBITDA margins moderated due to higher input costs and inflationary pressure from geopolitical disruptions. Pricing actions only partially mitigated cost increases.

ACI Godrej Agrovet Private Limited, Bangladesh (Joint Venture):

  • Demonstrated a strong comeback with robust topline growth driven by broad-based volume expansion across categories.
  • Profit Before Tax (PBT) increased YoY by 12% driven by operational leverage and volume growth.
  • Profit After Tax (PAT) declined YoY primarily due to a higher effective tax rate following a change in the applicable tax rate from 15% to 27.5% effective July 1, 2025. This impact is tax-related and not reflective of operating performance deterioration.

Document and Company Details

  • Submitted by: Vivek Pritamlal Raizada, Head- Legal & Company Secretary & Compliance Officer (ACS 11787)
  • Regulatory Reference: Submission to BSE and NSE regarding financial results.

The press release also includes a standard disclaimer stating it is for information purposes only and contains forward-looking statements subject to risks and uncertainties.